IL148547A - Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions - Google Patents
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditionsInfo
- Publication number
- IL148547A IL148547A IL148547A IL14854702A IL148547A IL 148547 A IL148547 A IL 148547A IL 148547 A IL148547 A IL 148547A IL 14854702 A IL14854702 A IL 14854702A IL 148547 A IL148547 A IL 148547A
- Authority
- IL
- Israel
- Prior art keywords
- embryonic
- stem
- methods
- cell lines
- tissue culture
- Prior art date
Links
- 230000013020 embryo development Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000004077 genetic alteration Effects 0.000 title 1
- 231100000118 genetic alteration Toxicity 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000010449 nuclear transplantation Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Psychology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39536899A | 1999-09-14 | 1999-09-14 | |
PCT/US2000/025090 WO2001019977A1 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148547A true IL148547A (en) | 2009-09-01 |
Family
ID=23562752
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14854700A IL148547A0 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
IL148547A IL148547A (en) | 1999-09-14 | 2002-03-06 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14854700A IL148547A0 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1214404A4 (en) |
JP (1) | JP2003525031A (en) |
CN (1) | CN1379814A (en) |
AU (1) | AU7701900A (en) |
BR (1) | BR0013999A (en) |
CA (1) | CA2384413A1 (en) |
IL (2) | IL148547A0 (en) |
MX (1) | MXPA02002744A (en) |
NZ (1) | NZ517609A (en) |
WO (1) | WO2001019977A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7696404B2 (en) | 1996-08-19 | 2010-04-13 | Advanced Cell Technology, Inc. | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
EP1214403A4 (en) * | 1999-09-07 | 2005-03-09 | Advanced Cell Tech Inc | Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
AU782385B2 (en) * | 1999-10-15 | 2005-07-21 | Advanced Cell Technology, Inc. | Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
AU784731B2 (en) * | 1999-12-20 | 2006-06-08 | University Of Massachusetts | Embryonic or stem-like cells produced by cross species nuclear transplantation |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
IL128348A (en) * | 1996-08-19 | 2008-08-07 | Univ Massachusetts | Method of producing embryonic or stem like cell lines by transplantation of cell nuclei from animal or mammal, such cells and uses thereof |
AU8587598A (en) * | 1997-07-26 | 1999-02-16 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
JP2002505100A (en) * | 1998-03-02 | 2002-02-19 | ユニヴァーシティー オヴ マサチューセッツ アパブリック インスティテューション オヴ ハイアー エデュケイション オヴ ザ コモンウェルス オヴ マサチューセッツ リプレゼンティド バイイッツ アム | Embryonic or stem cell-like cell lines generated by interspecies nuclear transfer |
AU784731B2 (en) * | 1999-12-20 | 2006-06-08 | University Of Massachusetts | Embryonic or stem-like cells produced by cross species nuclear transplantation |
-
2000
- 2000-09-14 BR BR0013999-8A patent/BR0013999A/en not_active Application Discontinuation
- 2000-09-14 CN CN00814278A patent/CN1379814A/en active Pending
- 2000-09-14 MX MXPA02002744A patent/MXPA02002744A/en not_active Application Discontinuation
- 2000-09-14 AU AU77019/00A patent/AU7701900A/en not_active Abandoned
- 2000-09-14 CA CA002384413A patent/CA2384413A1/en not_active Abandoned
- 2000-09-14 JP JP2001523749A patent/JP2003525031A/en active Pending
- 2000-09-14 NZ NZ517609A patent/NZ517609A/en unknown
- 2000-09-14 IL IL14854700A patent/IL148547A0/en unknown
- 2000-09-14 EP EP00966717A patent/EP1214404A4/en not_active Withdrawn
- 2000-09-14 WO PCT/US2000/025090 patent/WO2001019977A1/en active IP Right Grant
-
2002
- 2002-03-06 IL IL148547A patent/IL148547A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA02002744A (en) | 2003-07-21 |
JP2003525031A (en) | 2003-08-26 |
BR0013999A (en) | 2002-05-21 |
WO2001019977A1 (en) | 2001-03-22 |
EP1214404A4 (en) | 2003-09-03 |
CA2384413A1 (en) | 2001-03-22 |
IL148547A0 (en) | 2002-09-12 |
NZ517609A (en) | 2004-02-27 |
CN1379814A (en) | 2002-11-13 |
AU7701900A (en) | 2001-04-17 |
WO2001019977A9 (en) | 2002-09-26 |
EP1214404A1 (en) | 2002-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022180D0 (en) | Hematopoietic differentiation of human embryonic stem cells | |
IL207268A0 (en) | Methods of culture systems of preparing feeder cells - free, xeno - free human embryonic stem cells and stem cell cultures prepared using same | |
IL128348A0 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
NZ336612A (en) | Cloning using donor nuclei from proliferating somatic cells | |
MXPA02004333A (en) | Use of haploid genomes for genetic diagnosis, modification and multiplication. | |
NO20033396D0 (en) | Improved in vitro method for culturing mammalian cells for autologous cell implantation / transplantation methods | |
AU3914300A (en) | Cell culture apparatus and method for culturing cells | |
NZ513888A (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
EP1385933A4 (en) | Culture medium for cell growth and transfection | |
PL328922A1 (en) | Culture medium for growing mammal tissue cells | |
EP1017423A4 (en) | Cloning pigs using donor nuclei from differentiated cells | |
AU2575701A (en) | Sugarbeet regeneration and transformation | |
WO2002072762A3 (en) | Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture | |
IL181437A0 (en) | Medium and culture of embryonic stem cells | |
IL141735A (en) | Method of culturing embryonic stem cells | |
IL150065A0 (en) | Embryonic or stem-like cells produced by cross species nuclear transplantation | |
IL148547A0 (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions | |
EP1238059A4 (en) | Long-term cell culture compositions and genetically modified animals derived therefrom | |
GB0304284D0 (en) | Carrier for cell culture and method for culturing cells | |
IL149071A0 (en) | Preparation and selection of donor cells for nuclear transplantation | |
IL138201A0 (en) | Embryonic or stem-like cell lines produced by cross-species nuclear transplantation | |
EP1056835A4 (en) | Derivation of cells and tissues from embryonic pre-stem cells for transplantation therapies | |
MXPA02001400A (en) | Avian blastodermal cell lines. | |
NO20006051L (en) | Method for the preparation of culture of cell aggregates referred to as primorphs from dissociated cells from sponges, corals and other invertebrates, and their use | |
PL329830A1 (en) | Method of and apparatus for controlling growth of procariotic and eucariotic cells as well as activity of enzymes and functions of genes in biotechnological laboratory cell cultures and in natural living organisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |